ArticleAnalytical and bioanalytical chemistry2026
Dual template (epitope) imprinting of Mycobacterium leprae bacterial protein for enhanced MIP-EQCM sensing.
Article in Analytical and bioanalytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Leprosy, often known as Hansen's disease, is a chronic bacterial infection caused by Mycobacterium leprae (M. leprae) bacteria. The bacterium has a long incubation period, making it challenging for diagnosis. Timely diagnosis is crucial in initiating early treatment and preventing disease progression and complications. Herein, we proposed a dual-epitope imprinted polymer sensor for M. leprae bacterial protein. Two peptide (epitope) sequences unique to the bacteria were selected and immobilized onto gold nanoparticles, followed by polymerization using multiple monomers 2-methacryloyloxyethyl phosphorylcholine (2-MPC), benzyl methacrylate (BM), and 4-aminothiophenol (4-ATP), selected through in silico molecular docking strategy and ethylene glycol dimethacrylate (EGDMA) as a cross-linker. The imprinted polymer was electrodeposited on the gold coated electrochemical quartz crystal microbalance (EQCM) electrode. The sensor was able to show specific binding towards the real blood samples of leprosy patients. The limit of detection (1.39-1.82 nM) and limit of quantification (4.20-5.51 nM) with no cross reactivity and matrix effect indicate high sensitivity and selectivity. The sensor exhibits a significant improvement in selectivity and adsorption capacity over conventional sensors, with add-on advantages of reusability, high selectivity and sensitivity.
Indexed as
Identifiers
42726233What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.